Hicks, Rodney J. http://orcid.org/0000-0002-0758-0824
Article History
Received: 4 December 2022
Accepted: 1 March 2023
First Online: 5 April 2023
Declarations
:
: Not relevant for review article.
: Provided as sole author.
: I declare a conflict of interest as the Co-Editor-in-Chief of Cancer Imaging and a major shareholder in Precision Molecular Imaging and Theranostics Pty. Ltd., which has installed a Siemens Biograph Vision Quadra PET/CT and will receive research collaboration funding from Siemens Healthineers.I am also a shareholder of PreMIT Pty Ltd, a research and development company involved in development of novel diagnostic and therapeutic radiopharmaceuticals, and in Telix Pharmaceuticals, a listed Biotechnology Company on the Australian Stock Exchange.